Matthew Robers
Target 2035 invited speaker Matthew Robers is a Senior Research Scientist and Group Leader at Promega Corporation. Matthew received post-graduate training at University of Wisconsin-Madison, studying iron-sulfur cluster enzymes in bacteria. Following graduate school, Matthew emphasized technology development for cellular pathway analysis at Life Technologies (Invitrogen). Since joining Promega, Matthew has built a team focused on the development of new technologies to assess intracellular target engagement and drug polypharmacology. Matthew has authored over 10 patents underlying biophysical techniques for quantifying compound affinity and engagement kinetics within intact cells. Matthew currently emphasizes external collaborations with leaders in drug discovery and has authored over 50 peer-reviewed publications focused on mechanistic analysis of drug-target engagement in cells.
Abstracts this author is presenting:
